CCA
CL icon

Cypress Capital Advisors’s Colgate-Palmolive CL Stock Holding History

Cypress Capital Advisors’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$596K Buy
6,998
+3,952
+130% +$352K 0.32% 50
2025
Q4 		$241K Sell
3,046
-4,143
-58% -$325K 0.13% 68
2025
Q3 		$575K Sell
7,189
-274
-4% -$23.4K 0.33% 51
2025
Q2 		$678K Buy
7,463
+365
+5% +$33.3K 0.42% 46
2025
Q1 		$665K Buy
+7,098
New +$636K 0.46% 46

Other funds holding CL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Cypress Capital Advisors's CL Position: Q1 2026 in Review

Cypress Capital Advisors increased its Colgate-Palmolive (CL) stake by 130% in Q1 2026, buying an estimated $352K and bringing the position to 6,998 shares worth $596K. The position accounts for 0.32% of the portfolio, ranked #50.

Cypress Capital Advisors first reported a position in CL in Q1 2025 and has held it in 5 quarters since. The position peaked at $678K in Q2 2025. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Cypress Capital Advisors held 6,998 shares of Colgate-Palmolive worth $596K as of Q1 2026.
  • Cypress Capital Advisors bought 3,952 Colgate-Palmolive shares in Q1 2026, an estimated $352K.
  • Colgate-Palmolive made up 0.32% of Cypress Capital Advisors's portfolio in Q1 2026, its #50 holding.
  • Cypress Capital Advisors first reported a position in Colgate-Palmolive in Q1 2025 and has held it in 5 quarters since.
  • Cypress Capital Advisors's Colgate-Palmolive position peaked at $678K in Q2 2025.
  • 1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Cypress Capital Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.